Dr. Arnold is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
5844 NW Barry Rd
Ste 230
Kansas City, MO 64154Phone+1 816-751-8900Fax+1 816-751-8630
Education & Training
- Washington University/B-JH/SLCH ConsortiumFellowship, Cardiovascular Disease, 2008 - 2012
- Washington University/B-JH/SLCH ConsortiumResidency, Internal Medicine, 2004 - 2007
- Ohio State University College of MedicineClass of 2004
Certifications & Licensure
- KS State Medical License 2012 - 2025
- MO State Medical License 2007 - 2025
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Cardiovascular Disease
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification NextGen Ambulatory EHR, NextGen Healthcare, 2012-2013
Publications & Presentations
PubMed
- 1 citationsQuality of Life After Transcatheter Tricuspid Valve Replacement: 1-Year Results From TRISCEND II Pivotal Trial.Suzanne V Arnold, Rebecca T Hahn, Vinod H Thourani, Raj Makkar, Moody Makar
Journal of the American College of Cardiology. 2025-01-28 - The FINE ART of Interpreting Health Status Benefits in Clinical Trials.John A Spertus, David J Cohen, Suzanne V Arnold
Journal of the American College of Cardiology. 2025-01-21 - 1 citationsInterpreting Population Mean Treatment Effects in the Kansas City Cardiomyopathy Questionnaire: A Patient-Level Meta-Analysis.Mohammad Abdel Jawad, Philip G Jones, Suzanne V Arnold, David J Cohen, Charles F Sherrod
JAMA Cardiology. 2025-01-01
Journal Articles
- Interpretation of the Seattle Angina Questionnaire as an Outcome Measure in Clinical Trials and Clinical CareSuzanne (Gehrke) Arnold, MD, JAMA Cardiology
- Special Focus Issue: Blood Pressure Original Investigation Low Diastolic Blood Pressure Is Associated with Angina in Patients with Chronic Coronary Artery DiseaseSuzanne V Arnold, John A Spertus, ScienceDirect
- Real‐World Opportunity of Empagliflozin to Improve Blood Pressure Control in African Americans with Type 2 Diabetes: An NCDR® “Research‐to‐Practice” Project from the D...Suzanne V Arnold, Mikhail Kosiborod, Diabetes, Obesity and Metabolism
- Join now to see all
Press Mentions
- Imaging Specialist Rebecca Hahn Explores Key Details About the Evoque TTVR DeviceJanuary 16th, 2025
- Study Demonstrates Benefits of Edwards’ EVOQUE SystemDecember 11th, 2024
- Edwards’ Evoque System Evaluated in TRISCEND II for Clinical and QoL Benefits in Severe TRNovember 7th, 2024
- Join now to see all
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: